Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Creating a genotype-based dosing algorithm for acenocoumarol steady dose.

Thrombosis and haemostasis - 1 Jan 2013

Cerezo-Manchado Juan J, Rosafalco Mario, Antón Ana I, Pérez-Andreu Virginia, Garcia-Barberá Nuria, Martinez Ana B, Corral Javier, Vicente Vincente, González-Conejero Rocio, Roldán Vanessa

Abstract excerpt

Acenocoumarol is a commonly prescribed anticoagulant drug for the prophylaxis and treatment of venous and arterial thromboembolic disorders in several countries. In counterpart of warfarin, there is scarce information about pharmacogenetic algorithms for steady acenocoumarol dose estimation. The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fibrinolytic Agents
Share to Acenocoumarol
Share to Blood Coagulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytochrome P450 Family 4

Share to Drug Dosage Calculations

Share to Drug Monitoring

Share to Least-Squares Analysis

Share to Vitamin K Epoxide Reductases

Source

Identifiers

PMID: 23196355
DOI: 10.1160/TH12-08-0631

Genes

VKORC1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23196355-2026-09-04.1. Manifest publication-graph-cohort-2026-09-04.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Creating a genotype-based dosing algorithm for acenocoumarol steady dose.PMID 23196355Read ↗

Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.Semantic proximity Read ↗

Clinical and genetic factors influencing acenocoumarol dosing: a cross-sectional study.Semantic proximity Read ↗

Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.Semantic proximity Read ↗

A novel, single algorithm approach to predict acenocoumarol dose based on CYP2C9 and VKORC1 allele variants.Semantic proximity Read ↗

Pharmacogenetics of acenocoumarol in patients with extreme dose requirements.Semantic proximity Read ↗

Effect of CYP2C9, VKORC1, CYP4F2, and GGCX gene variants and patient characteristics on acenocoumarol maintenance dose: Proposal for a dosing algorithm for Moroccan patients.Semantic proximity Read ↗

CYP2C9 and VKORC1 in therapeutic dosing and safety of acenocoumarol treatment: implication for clinical practice in Hungary.Semantic proximity Read ↗

A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort StudySemantic proximity Read ↗

Influence of genetic and non-genetic factors on acenocoumarol maintenance dose requirement in a Tunisian population.Semantic proximity Read ↗

Evaluation of genotype-guided acenocoumarol dosing algorithms in Russian patients.Semantic proximity Read ↗

The pediatric acenocoumarol dosing algorithm: the Children Anticoagulation and Pharmacogenetics Study.Semantic proximity Read ↗

Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.